Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension - Wikidata - awgldk - TriplyDB

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension

http://www.wikidata.org/entity/Q34621390

about

A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system Clinically Relevant Doses of Enalapril Mitigate Multiple Organ Radiation Injury.Effects of cardiovascular disease on pharmacokinetics.Enalapril: a long-acting angiotensin-converting enzyme inhibitor.Long-term therapy with benazepril in patients with congestive heart failure: effects on clinical status and exercise tolerance.An overview of the clinical pharmacology of enalapril.The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.

P2860

Q36595721-9133299D-3D44-4ADA-BC4E-3A447EAECB73 Q36781470-6A2165BA-6B14-40C4-8C2D-EAD0A871E9AB Q38378935-B5725A04-6506-4C7A-8B60-C776F57708AA Q39177686-1868FB79-3FFC-4DCE-8A56-9BA3822BDEE6 Q39513638-4BF81259-5BAA-4F19-85C7-9DF5C4A09118 Q40080622-7795534D-F25D-4C8B-87F4-1FF0114AE424 Q42229384-F204CA07-E20B-4D9E-A576-C6CEB1733B22

P2860

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension

http://www.wikidata.org/entity/Q34621390

description

1984 nî lūn-bûn

@nan

1984 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1984 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

name

Plasma enalapril levels and ho ...... tion in essential hypertension

@ast

Plasma enalapril levels and ho ...... tion in essential hypertension

@en

Plasma enalapril levels and ho ...... tion in essential hypertension

@nl

type

label

Plasma enalapril levels and ho ...... tion in essential hypertension

@ast

Plasma enalapril levels and ho ...... tion in essential hypertension

@en

Plasma enalapril levels and ho ...... tion in essential hypertension

@nl

prefLabel

Plasma enalapril levels and ho ...... tion in essential hypertension

@ast

Plasma enalapril levels and ho ...... tion in essential hypertension

@en

Plasma enalapril levels and ho ...... tion in essential hypertension

@nl

P1433

Q34621390-6CDBD791-510E-45A2-BB40-B4CE4EB7FB2E

P1476

Q34621390-974A1B85-FC94-427B-9A20-E1B8A1626234

P2093

Q34621390-241A73B4-C098-4526-A4FA-365A7625DD1A

Q34621390-A3E8D0E4-94B5-4671-847E-07C951DFBE64

Q34621390-C425D5F5-CEB3-4AE9-A8E6-654270342E81

Q34621390-D9F18D7F-681E-43B5-AB13-AE2D0048A0A8

Q34621390-E1559EFB-C059-49D7-87B0-F6D678DD8DC4

P2860

Q34621390-1773F0B8-118D-455F-BC62-0C08C52992BC

Q34621390-23832ABC-BFD2-438E-B5C8-F6F66214F9DF

Q34621390-4C56007F-1D4B-4C49-B5DF-24794DF62AC6

Q34621390-59291F6C-02E5-4E41-93F1-C430CFEE83AA

Q34621390-83185B02-892E-4E31-87B5-72DA51BA8068

Q34621390-C12113DA-459B-4F2F-AC8C-CCF9FE23E04C

Q34621390-C18030B4-EA5B-4B5E-A26E-09E157BF00B6

Q34621390-C2DEC2EF-2AA9-4CF1-8AD6-B3BB13DCE90D

Q34621390-D0C78D4D-DF09-49DD-ACF6-495C363202F7

Q34621390-DE5748CC-71C4-467A-8387-69C0EC11E458

P304

Q34621390-28D32DC7-31D0-4C19-97A4-074DFC8D3B92

P31

Q34621390-9E3E058F-35A4-4169-B779-45F4E6AF9701

P356

Q34621390-2D8744D6-C8F0-4794-986B-FDA3ABCE7837

P407

Q34621390-F977CCBA-26DE-47D7-91F6-B23218B292C3

P478

Q34621390-D1D9ED57-0CB4-4B78-842F-BF03A1B77463

P577

Q34621390-4D07AF3D-4F07-4C68-B067-7B2D9015BC19

P5875

Q34621390-83FDC8DB-695A-4C1D-9BF0-E08D669F4422

P698

Q34621390-862C2BD3-BD89-40BA-A004-882B8473235A

P932

Q34621390-58555ED2-7323-4D71-BB74-F5BB714B51C0

P356

J.1365-2125.1984.TB02602.X

P1433

British Journal of Clinical Pharmacology

P1476

Plasma enalapril levels and ho ...... tion in essential hypertension

@en

P2093

Casley D

http://www.w3.org/2001/XMLSchema#string

Cubella R

http://www.w3.org/2001/XMLSchema#string

Jackson BJ

http://www.w3.org/2001/XMLSchema#string

Johnston CI

http://www.w3.org/2001/XMLSchema#string

Larmour I

http://www.w3.org/2001/XMLSchema#string

P2860

A new class of angiotensin-converting enzyme inhibitors.

The physiological disposition and metabolism of enalapril maleate in laboratory animals.

Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.

Enzymes of the renin-angiotensin system and their inhibitors.

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Medical intelligence drug therapy: captopril.

Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

P304

233S-239S, 241S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1984.TB02602.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

18 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

1984-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

17086043

http://www.w3.org/2001/XMLSchema#string

P698

6099738

http://www.w3.org/2001/XMLSchema#string

P932

1463475

http://www.w3.org/2001/XMLSchema#string